Evaggelia-Evdoxia Koravou
Overview
Explore the profile of Evaggelia-Evdoxia Koravou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
68
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Papakonstantinou A, Kalmoukos P, Mpalaska A, Koravou E, Gavriilaki E
Int J Mol Sci
. 2024 Aug;
25(15).
PMID: 39125707
Thrombotic thrombocytopenic purpura (TTP) is a life-threatening, often immune-mediated disease that affects 2-13 persons per million per year. Hemolytic anemia, thrombocytopenia, and end-organ damage due to the formation of microthrombi...
2.
Venou T, Vetsiou E, Varelas C, Daniilidis A, Psarras K, Koravou E, et al.
J Pers Med
. 2024 Apr;
14(4).
PMID: 38673014
Preeclampsia is a progressive multi-systemic disorder characterized by proteinuria, critical organ damage, and new-onset hypertension. It can be further complicated by HELLP syndrome (hemolysis, elevated liver enzymes, low platelets), resulting...
3.
Koletsos N, Lazaridis A, Triantafyllou A, Anyfanti P, Lamprou S, Stoimeni A, et al.
J Clin Med
. 2024 Apr;
13(7).
PMID: 38610905
: Systemic lupus erythematosus (SLE) is a prototype autoimmune disease associated with increased cardiovascular (CV) burden. Besides increased arterial stiffness and subclinical atherosclerosis, microvascular dysfunction is considered an important component...
4.
Gavriilaki E, Bousiou Z, Batsis I, Vardi A, Mallouri D, Koravou E, et al.
Int J Mol Sci
. 2024 Jan;
25(1).
PMID: 38203404
Hematopoietic stem cell transplantation-associated thrombotic microangiopathy (HSCT-TMA) and graft-versus-host disease (GvHD) represent life-threatening syndromes after allogeneic hematopoietic stem cell transplantation (allo-HSCT). In both conditions, endothelial dysfunction is a common denominator,...
5.
Tsiftsoglou S, Gavriilaki E, Touloumenidou T, Koravou E, Koutra M, Papayanni P, et al.
Immunobiology
. 2023 Feb;
228(2):152351.
PMID: 36805858
We have attempted to explore further the involvement of complement components in the host COVID-19 (Coronavirus disease-19) immune responses by targeted genotyping of COVID-19 adult patients and analysis for missense...
6.
Gavriilaki E, Tsiftsoglou S, Touloumenidou T, Farmaki E, Panagopoulou P, Michailidou E, et al.
Curr Issues Mol Biol
. 2022 Jul;
44(7):2811-2824.
PMID: 35877417
Complement dysregulation has been documented in adults with COVID-19 and implicated in relevant pediatric inflammatory responses against SARS-CoV-2. We propose that signatures of complement missense coding SNPs associated with dysregulation...
7.
Gavriilaki E, Dalampira D, Theodorakakou F, Liacos C, Kanellias N, Eleutherakis-Papaiakovou E, et al.
J Clin Med
. 2022 Jun;
11(12).
PMID: 35743426
Background: Carfilzomib, an irreversible proteasome inhibitor approved for the treatment of relapsed/refractory Multiple Myeloma (MM) has been associated with Thrombotic Microangiopathy (TMA). Several pathogenetic mechanisms of carfilzomib-induced TMA have been...
8.
Gavriilaki E, Papadopoulou A, Touloumenidou T, Stavridou F, Koravou E, Giannaki M, et al.
Bone Marrow Transplant
. 2022 Apr;
57(7):1183-1186.
PMID: 35449455
No abstract available.
9.
Koletsos N, Dipla K, Triantafyllou A, Lazaridis A, Papadopoulos N, Dolgyras P, et al.
Clin Exp Rheumatol
. 2022 Mar;
41(1):6-14.
PMID: 35238763
Objectives: Subclinical brain lesions have been reported in systemic lupus erythematosus (SLE) patients. Advanced neuroimaging techniques have revealed microstructural and microvascular alterations. Most studies examining structural or functional brain abnormalities...
10.
Varelas C, Gavriilaki E, Sakellari I, Klonizakis P, Koravou E, Christodoulou I, et al.
J Clin Med
. 2022 Feb;
11(4).
PMID: 35207208
Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are essential weapons to control the spread of the coronavirus disease-19 (COVID-19) pandemic and protect immunocompromised patients. With a greater susceptibility...